ReviewFrontiers in oncology2019

Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib.

Elena Maria Elli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.